Figures 4A–C shows examples of the top nominally significant reduced levels of these triacylglycerols based on disease severity in hypertensive patients.
← all excerpts
Metabolic Signatures of Type 2 Diabetes Mellitus and Hypertension in COVID-19 Patients With Different Disease Severity.
1
—
—